Chinese Markets for Ovarian Cancer Treatment Drugs

Publication Date	April 2009
Publisher	AMID
Product Type	Report
Pages	243
ISBN Number	not applicable
Product Code	AMI00403

Buy this product or for assistance call +44 20 7060 7474

PRINT £2,405.00$4001 | €2692

FAX Order above formats by FAX

Summary

China's demand for Ovarian Cancer Treatment Drugs has grown at a fast pace in the past decade. In the next five years, both production and demand will continue to grow. This new study examines China's economic trends, investment environment, industry development, supply and demand, industry capacity, industry structure, marketing channels and major industry participants. Historical data (1998, 2003 and 2008) and long-term forecasts throught 2013 and 2018 are presented. Major producers in China are profiled.

Content

List of Tables
I. INTRODUCTION
- Report Scope and Methodology
- Executive Summary
II. BUSINESS ENVIRONMENT
- Economic Outlook
- Key Economic Indicators
- Industrial Output
- Population and Labor
- Foreign Investment
- Foreign Trade
- Financial and Tax Regulations
- Banking System and Regulations
- Foreign Exchange
- Taxes, Tariff and Custom Duties
III. OVARIAN CANCER TREATMENT DRUGS INDUSTRY ASSESSMENTS
- Ovarian Cancer Treatment Drugs Industry Structure
- Market Size
- Market Growth Driver
- Ovarian Cancer Treatment Drugs Sales Volume
- Major Producer Facility Locations
- Major Producers' Sales Volume and Market Share
- Paclitaxel
- Platinum Anticancer Drugs
- Fluoropyrimidines
- Anthracycline Antibiotics
- Therapertic Antibody
- Small Molecules Drug
- Aromatase Inhibitors (Targeted Therapy Drug)
- Anti-estrogens
- Aromatase Inhibitors (Endocrine Therapy Drug)
- LH-RH
- Labor Cost
- Potential Entrants
- Major Distributors
- Major Foreign Investments
- Technology Development
IV. OVARIAN CANCER TREATMENT DRUGS PRODUCTION AND DEMAND
- Overview
- Ovarian Cancer Treatment Drugs Sales Volume
- Chemotherapeutic Drug
- Paclitaxel
- Fluoropyrimidines
- Anthracycline Antibiotics
- Platinum Anticancer Drugs
- Targeted Therapy Drug
- Therapertic Antibody
- Small Molecules Drug
- Aromatase Inhibitors (Targeted Therapy Drug)
- Endocrine Therapy Drug
- Anti-estrogens
- Aromatase Inhibitors (Endocrine Therapy Drug)
- LH-RH
- Ovarian Cancer Treatment Drugs Import
- Chemotherapeutic Drug
- Paclitaxel
- Fluoropyrimidines
- Anthracycline Antibiotics
- Platinum Anticancer Drugs
- Targeted Therapy Drug
- Therapertic Antibody
- Small Molecules Drug
- Aromatase Inhibitors (Targeted Therapy Drug)
- Endocrine Therapy Drug
- Anti-estrogens
- Aromatase Inhibitors (Endocrine Therapy Drug)
- LH-RH
- Pricing Trend
V. OVARIAN CANCER TREATMENT DRUGS MARKET OUTLOOK
- Ovarian Cancer Treatment Drugs Markets Outlook Overview Concrete Government Regulations
- Health Care Insurance Industry Overview
- Consumer Spending Trends
- Demographic Trends
- Health Care Industry Trends
- Hospitals and Hospital Beds
- Physicians and Physician Visits
VI. MARKET ENTRY CHANNELS
- China Market Entry Overview
- China's Distribution System
- Ovarian Cancer Treatment Drugs Distribution Channels
- Transportation and Freight Infrastructure
- Communications
- China's Market Entry
- Export to China
- Indirect export
- Direct Export
- License and Contract Manufacture
- Assembling in China
- Contract Manufacturing
- Trade Permit
- Investment
- Equity Joint Venture
- Contractual Joint Venture
- Wholly Foreign-Owned Enterprise
VII. ANTIFREEZE & THAWING AGENT PRODUCER DIRECTORY
- Ovarian Cancer Treatment Drugs Producer Profiles and Directory
LIST OF TABLES
I. INTRODUCTION
- Economic Outlook Summary
II. BUSINESS ENVIRONMENT
- Key Economic Indicators
- Industrial Output
- Population and Labor Force Trends
- Foreign Investment and Loans
- Foreign Trade
III. OVARIAN CANCER TREATMENT DRUGS INDUSTRY ASSESSMENTS
- Ovarian Cancer Treatment Drugs Sales Volume
- Chemotherapeutic Drug Sales Volume and Market Share by Drugs Classification
- Targeted Therapy Drug Sales Volume and Market Share by Drugs Classification
- Endocrine Therapy Drug Sales Volume and Market Share by Drugs Classification
- Major Producer Facility Locations
- Major Ovarian Cancer Treatment Drugs Producer Sales Volume and Market Share
- Major Foreign Investments
IV. OVARIAN CANCER TREATMENT DRUGS PRODUCTION AND DEMAND
- Total Ovarian Cancer Treatment Drugs Sales Volume
- Ovarian Cancer Treatment Drugs Major Producer and Their Market Share
- Chemotherapeutic Drug Sales Volume and Market Share by Drugs Classification
- Chemotherapeutic Drug Major Producer and Their Market Share
- Paclitaxel Major Producer and Their Market Share
- Fluoropyrimidines Major Producer and Their Market Share
- Anthracycline Antibiotics Major Producer and Their Market Share
- Platinum Anticancer Drugs Major Producer and Their Market Share
- Targeted Therapy Drug Sales Volume and Market Share by Drugs Classification
- Targeted Therapy Drug Major Producer and Their Market Share
- Therapertic Antibody Major Producer and Their Market Share
- Small Molecules Drug Major Producer and Their Market Share
- Aromatase Inhibitors (Targeted Therapy Drug) Major Producer and Their Market Share
- Endocrine Therapy Drug Sales Volume and Market Share by Drugs Classification
- Endocrine Therapy Drug Major Producer and Their Market Share
- Anti-estrogens Major Producer and Their Market Share
- Aromatase Inhibitors (Endocrine Therapy Drug) Major Producer and Their Market Share
- LH-RH Major Producer and Their Market Share
- Ovarian Cancer Treatment Drugs Import
V. OVARIAN CANCER TREATMENT DRUGS MARKET OUTLOOK
- Consumer Spending Trends
- Demographic Trends
- Health Care Industry Trends
- Hospitals and Hospital Beds
- Physicians and Physician Visits
LIST OF CHARTS
I. INTRODUCTION
- Ovarian Cancer Treatment Drugs Sales Volume
II. BUSINESS ENVIRONMENT
- China's GDP and Growth Rate
- Industrial Output by Ownership
- China's Imports and Exports
III. OVARIAN CANCER TREATMENT DRUGS INDUSTRY ASSESSMENTS
- Chemotherapeutic Drug Sales Volume by Drugs Classification
- Targeted Therapy Drug Sales Volume by Drugs Classification
- Endocrine Therapy Drug Sales Volume by Drugs Classification
- Ovarian Cancer Treatment Drugs Sales Volume
IV. OVARIAN CANCER TREATMENT DRUGS PRODUCTION AND DEMAND
- Ovarian Cancer Treatment Drugs Sales Volume
- Chemotherapeutic Drug Sales Volume and Market Share
- Chemotherapeutic Drug Sales Volume by Drugs Classification
- Paclitaxel Sales Volume and Market Share
- Fluoropyrimidines Sales Volume and Market Share
- Anthracycline Antibiotics Sales Volume and Market Share
- Platinum Anticancer Drugs Sales Volume and Market Share
- Targeted Therapy Drug Sales Volume and Market Share
- Targeted Therapy Drug Sales Volume by Drugs Classification
- Therapertic Antibody Sales Volume and Market Share
- Small Molecules Drug Sales Volume and Market Share
- Aromatase Inhibitors (Targeted Therapy Drug) Sales Volume and Market Share
- Endocrine Therapy Drug Sales Volume and Market Share
- Endocrine Therapy Sales Volume by Drugs Classification
- Anti-estrogens Sales Volume and Market Share
- Progesterone Sales Volume and Market Share
- Aromatase Inhibitors (Endocrine Therapy Drug) Sales Volume and Market Share
- LH-RH Sales Volume and Market Share
- Ovarian Cancer Treatment Drugs Import
- Chemotherapeutic Drug Import and Market Share
- Chemotherapeutic Drug Import by Drugs Classification
- Paclitaxel Import and Market Share
- Fluoropyrimidines Import and Market Share
- Anthracycline Antibiotics Import and Market Share
- Platinum Anticancer Drugs Import and Market Share
- Targeted Therapy Drug Import and Market Share
- Targeted Therapy Drug Import by Drugs Classification
- Therapertic Antibody Import and Market Share
- Small Molecules Drug Import and Market Share
- Aromatase Inhibitors (Targeted Therapy Drug) Import and Market Share
- Endocrine Therapy Drug Import and Market Share
- Endocrine Therapy Drug Import by Drugs Classification
- Anti-estrogens Import and Market Share
- Progesterone Import and Market Share
- Aromatase Inhibitors (Endocrine Therapy Drug) Import and Market Share
- LH-RH Import and Market Share
V. OVARIAN CANCER TREATMENT DRUGS MARKET OUTLOOK
VI. MARKETING STRATEGIES
- China's Distribution Channel